Total recall: April and May see surge
This article was originally published in Clinica
Executive Summary
So far, the second quarter of 2013 has already seen more recalls than the first quarter, with a total of 17 passing Clinica’s news desk in April and the first half of May. This compares with 13 recalls in the whole of Q1, according to the US FDA’s website: there were four recalls in March, five in February, and four in January. See the table below for a full list of recent recalls.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.